Open AccessWithdrawal of Glucocorticoid Therapy is Difficult in Women with Polymyalgia Rheumatica: An Observational Study
Author(s) -
Dai Aoki,
Nobuyuki Kajiwara,
Keiko Irishio,
Yasuhiro Kato,
Shinya Suezaki,
Misaki Kageyama,
M Misago,
Daisuke Tamai,
Shinichiro Nakao,
Takato Ueoka,
Mototoshi Ito,
Shinichiro Murakami
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s322111
Subject(s) - medicine , polymyalgia rheumatica , erythrocyte sedimentation rate , gastroenterology , concomitant , glucocorticoid , anemia , disease , vasculitis , giant cell arteritis
A total of 105 patients (64 women) who were started on glucocorticoid (GC) treatment for polymyalgia rheumatica (PMR) and/or remitting seronegative symmetrical synovitis with pitting edema (RS 3 PE) syndrome at Ikeda City Hospital from July 2004 to December 2019 were reviewed (PMR: 81, overlap: 20, pure RS 3 PE syndrome: 4). Then, 32 cases that had stopped GC and 17 cases that had continued GC for 7.5 years or longer were evaluated (women:men, stopped GC 12:20, continued GC 13:4, respectively) (PMR:overlap:pure RS 3 PE syndrome, stopped GC 26:6:0, continued GC 14:2:1, respectively).